½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, °Ë»ç Àå¼Òº°, Áö¿ªº°
Cardiac Biomarkers Market, By Product Type, By Application, By Location of Testing, By Geography
»óǰÄÚµå : 1672758
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ¼¼°è ½ÃÀåÀº 2025³â¿¡´Â 171¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 13.5%·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 416¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 171¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR 13.50% 2032³â ±Ý¾× ¿¹Ãø 416¾ï 2,000¸¸ ´Þ·¯
±×¸². ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº°
Cardiac Biomarkers Market-IMG1

½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿´Â ½É±ÙÀÌ ¼Õ»óµÇ°Å³ª ½ºÆ®·¹½º¸¦ ¹ÞÀ» ¶§ Ç÷¾×¿¡ Á¸ÀçÇÏ´Â ´Ü¹éÁúÀ» ¸»ÇÕ´Ï´Ù. ´Ù¾çÇÑ ½ÉÀå ÁúȯÀ» °¨ÁöÇÏ°í ¸ð´ÏÅ͸µÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ² Áõ°¡¿Í ½ÉÀå ¹®Á¦¸¦ ÀÏÀ¸Å°±â ½¬¿î ¼¼°è ³ëÀεé Áõ°¡¸¦ ¹è°æÀ¸·Î Áö³­ ¸î ³âµ¿¾È Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼úÀÇ Áøº¸·Î ½ÉÀå ÁúȯÀÇ Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô ÇÏ´Â °í°¨µµ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ °³¹ßÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº °í·ÉÀÚ Áõ°¡, ½ÉÇ÷°ü ÁúȯÀÇ °æÁ¦Àû ºÎ´ã Áõ°¡, Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»çÀÇ Ã¤¿ë È®´ë, ¿¬±¸ °³¹ßÀÇ ÁøÇà¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ±×·¯³ª »õ·Î¿î ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ½ÂÀο¡ °üÇÑ ±ÔÁ¦»óÀÇ ¹®Á¦, ÀÎÁöµµ ºÎÁ·, ½Å±â¼úÀÇ ¹Þ¾ÆµéÀ̱⿡ ¼Ò±ØÀûÀÎ °Í µîÀÌ ½ÃÀå ÁøÃâ±â¾÷ÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­´Â ÀÇ·á ÁöÃâ Áõ°¡, ´ç´¢º´ ¹× »ýȰ ½À°üº´ ºÎ´ã Áõ°¡, ÇöÁö ÁøÃâ±â¾÷ÀÇ ´ëµÎ µî¿¡ ÀÇÇØ ½ÃÀå °³Ã´ÀÇ ±âȸ°¡ ÀÖ´Ù°í º¸¿©Áö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÁøÃâ±â¾÷Àº ȯÀÚÀÇ ¸ð´ÏÅ͸µ°ú °ü¸®¸¦ °³¼±Çϱâ À§ÇØ »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿ ÆÐ³Î°ú ÈÞ´ë¿ë °Ë»ç ÀåºñÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå-Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, ¿ëµµº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, °Ë»ç Àå¼Òº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ºÐ¼®°¡ Ãßõ

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiac Biomarkers Market is estimated to be valued at USD 17.14 Bn in 2025 and is expected to reach USD 41.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 17.14 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.50% 2032 Value Projection: USD 41.62 Bn
Figure. Cardiac Biomarkers Market Share (%), By Region 2025
Cardiac Biomarkers Market - IMG1

Cardiac biomarkers refer to proteins that are present in blood when the heart muscle is damaged or stressed. They help detect and monitor various heart conditions. The cardiac biomarkers market has been witnessing significant growth over the past few years driven by the rising incidence of cardiovascular diseases and growing elderly population worldwide who are more prone to cardiac issues. Furthermore, ongoing technological advancements are allowing for the development of more sensitive biomarkers that can enable the earlier detection of cardiac conditions.

Market Dynamics:

The global cardiac biomarkers market is driven by the increasing geriatric population, rising economic burden of cardiovascular diseases, growing adoption of point-of-care testing, and ongoing research & development. However, regulatory issues regarding the approval of new cardiac biomarkers, lack of awareness, and reluctant acceptance of new technologies pose challenges to market players. The market sees opportunities in developing economies due to increasing healthcare spending, growing diabetes and lifestyle disease burden, and emergence of local players. Key players are focusing on developing novel biomarker panels and portable testing devices for improved patient monitoring and management.

Key Features of the Study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Cardiac Biomarkers Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Cardiac Biomarkers Market, By Product Type, 2020 - 2032, (USD Bn)

6. Global Cardiac Biomarkers Market, By Application, 2020 - 2032, (USD Bn)

7. Global Cardiac Biomarkers Market, By Location of Testing, 2020 - 2032, (USD Bn)

8. Global Cardiac Biomarkers Market, By Region, 2020 - 2032, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â